Alaska Permanent Fund and Qatar Investment Authority were among the investors in a series C round for Codiak Biosciences, based on research at Gothenburg and Texas universities.

The round, backed by Illumina Ventures, brought in $10m in funding though some of that amount was in the form of convertible notes.

Cigna, Guardian Life Insurance, Hikma and Merck are part of a consortium that has provided $20.5m in series C funding to healthcare-focused AI software developer Prognos.

Merck returned for the series B round, which was previously revealed through a regulatory filing made in September 2017.

Medtronic, Novartis and SinoPharm are among the investors in a series B round for Semma Therapeutics, which is working on a treatment for patients suffering from diabetes.

SoftBank is aiming to acquire shares from existing investors in Flipkart, valuing the business at $9bn to $10bn for the deal.

The commercialisation firm, which launched operations down under earlier this year, has appointed several members to its senior executive team.